Hill DE, Chirukandoth S, Dubey JP. Biology and epidemiology of Toxoplasma gondii in man and animals. Anim Health Res Rev. 2005 Jun. 6(1):41-61. [QxMD MEDLINE Link].
Ferguson W, Mayne PD, Lennon B, Butler K, Cafferkey M. Susceptibility of pregnant women to toxoplasma infection--potential benefits for newborn screening. Ir Med J. 2008 Jul-Aug. 101(7):220-1. [QxMD MEDLINE Link].
El-Tantawy N, Darwish A, Eissa E. Seroprevalence of Toxoplasma gondii infection Among Β-Thalassemia Major Pediatric Population: Implications for Transfusion Transmissible Toxoplasmosis. Pediatr Infect Dis J. 2018 May 14. [QxMD MEDLINE Link].
Trikha I, Wig N. Management of toxoplasmosis in AIDS. Indian J Med Sci. 2001. 55:87-98. [QxMD MEDLINE Link].
Jones JL, Lopez A, Wilson M, et al. Congenital toxoplasmosis: a review. Obstet Gynecol Surv. 2001. 56:296-305. [QxMD MEDLINE Link].
Peyron F, Garweg JG, Wallon M, Descloux E, Rolland M, Barth J. Long-term impact of treated congenital toxoplasmosis on quality of life and visual performance. Pediatr Infect Dis J. 2011 Jul. 30(7):597-600. [QxMD MEDLINE Link].
Berrebi A, Assouline C, Bessieres MH, et al. Long-term outcome of children with congenital toxoplasmosis. Am J Obstet Gynecol. 2010 Jul 14. [QxMD MEDLINE Link].
Rostami A, Karanis P, Fallahi S. Advances in serological, imaging techniques and molecular diagnosis of Toxoplasma gondii infection. Infection. 2018 Jun. 46 (3):303-315. [QxMD MEDLINE Link].
Hampton MM. Congenital Toxoplasmosis: A Review. Neonatal Netw. 2015. 34 (5):274-8. [QxMD MEDLINE Link].
Pomares C, Montoya JG. Laboratory Diagnosis of Congenital Toxoplasmosis. J Clin Microbiol. 2016 Oct. 54 (10):2448-54. [QxMD MEDLINE Link].
Bonfioli AA, Orefice F. Toxoplasmosis. Semin Ophthalmol. 2005 Jul-Sep. 20(3):129-41. [QxMD MEDLINE Link].
Carellos EVM, de Andrade JQ, Romanelli RMC, Tibúrcio JD, Januário JN, Vasconcelos-Santos DV, et al. High Frequency of Bone Marrow Depression During Congenital Toxoplasmosis Therapy in a Cohort of Children Identified by Neonatal Screening in Minas Gerais, Brazil. Pediatr Infect Dis J. 2017 Dec. 36 (12):1169-1176. [QxMD MEDLINE Link].
Foulon W, Naessens A, Ho-Yen D. Prevention of congenital toxoplasmosis. J Perinat Med. 2000. 28:337-45. [QxMD MEDLINE Link].
Paquet C, Yudin MH. Toxoplasmosis in pregnancy: prevention, screening, and treatment. J Obstet Gynaecol Can. 2013 Jan. 35(1):78-9. [QxMD MEDLINE Link].
McLeod R, Boyer K, Karrison T, et al. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin Infect Dis. 2006 May 15. 42(10):1383-94. [QxMD MEDLINE Link].
Felix JP, Lira RP, Zacchia RS, Toribio JM, Nascimento MA, Arieta CE. Trimethoprim-sulfamethoxazole versus placebo to reduce the risk of recurrences of Toxoplasma gondii retinochoroiditis: randomized controlled clinical trial. Am J Ophthalmol. 2014 Apr. 157 (4):762-766.e1. [QxMD MEDLINE Link].
Harding A. Trimethoprim-Sulfamethoxazole Prevents Ocular Toxoplasmosis Recurrence. Reuters Health Information. Available at http://www.medscape.com/viewarticle/819812. January 27, 2014; Accessed: September 17, 2015.
Zhang Y, Lin X, Lu F. Current treatment of ocular toxoplasmosis in immunocompetent patients: a network meta-analysis. Acta Trop. 2018 Sep. 185:52-62. [QxMD MEDLINE Link].

Author

Itzhak Brook, MD, MSc Professor, Department of Pediatrics, Georgetown University School of Medicine

Itzhak Brook, MD, MSc is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians-American Society of Internal Medicine, American Medical Association, American Society for Microbiology, Association of Military Surgeons of the US, Infectious Diseases Society of America, International Immunocompromised Host Society, International Society for Infectious Diseases, Medical Society of the District of Columbia, New York Academy of Sciences, Pediatric Infectious Diseases Society, Society for Experimental Biology and Medicine, Society for Pediatric Research, Southern Medical Association, Society for Ear, Nose and Throat Advances in Children, American Federation for Clinical Research, Surgical Infection Society, Armed Forces Infectious Diseases Society

Disclosure: Nothing to disclose.

Coauthor(s)

Hakan Leblebicioglu, MD Fellow, European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Honorary Chair of ESCMID Study Group for Infections in Travelers and Migrants (ESGITM); Professor of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis University School of Medicine, Turkey

Hakan Leblebicioglu, MD is a member of the following medical societies: American Society for Microbiology, European Society of Clinical Microbiology and Infectious Diseases

Disclosure: Nothing to disclose.

Murat Hökelek, MD, PhD Professor, Department of Clinical Microbiology, Istanbul University Cerrahpasa Medical Faculty, Turkey

Murat Hökelek, MD, PhD is a member of the following medical societies: American Society for Microbiology, Turkish Society for Parasitology

Disclosure: Nothing to disclose.

Specialty Editor Board

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Chief Editor

Russell W Steele, MD Clinical Professor, Tulane University School of Medicine; Staff Physician, Ochsner Clinic Foundation

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, Southern Medical Association

Disclosure: Nothing to disclose.